These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30359884)

  • 1. Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs.
    Mao Y; Feng S; Li S; Zhao Q; Di D; Liu Y; Wang S
    Biomaterials; 2019 Jan; 188():173-186. PubMed ID: 30359884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.
    Zheng B; Pan F; Shi M; He C; He B; Wang R; Ren G; Yang S; Zhang S
    Int J Nanomedicine; 2024; 19():5273-5295. PubMed ID: 38859952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir.
    Garg B; Katare OP; Beg S; Lohan S; Singh B
    Colloids Surf B Biointerfaces; 2016 May; 141():611-622. PubMed ID: 26916320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.
    Elsheikh MA; Elnaggar YSR; Otify DY; Abdallah OY
    Pharm Res; 2018 Jan; 35(1):18. PubMed ID: 29305670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach.
    Makwana V; Jain R; Patel K; Nivsarkar M; Joshi A
    Int J Pharm; 2015 Nov; 495(1):439-446. PubMed ID: 26367780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QbD based development of proliposome of lopinavir for improved oral bioavailability.
    Patel GM; Shelat PK; Lalwani AN
    Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosodium glutamate inhibits the lymphatic transport of lipids in the rat.
    Kohan AB; Yang Q; Xu M; Lee D; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G648-G654. PubMed ID: 27514481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability.
    Hu L; Quach T; Han S; Lim SF; Yadav P; Senyschyn D; Trevaskis NL; Simpson JS; Porter CJ
    Angew Chem Int Ed Engl; 2016 Oct; 55(44):13700-13705. PubMed ID: 27482655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport.
    Tu L; Wang J; Sun Y; Wan Y
    AAPS PharmSciTech; 2024 Sep; 25(7):206. PubMed ID: 39237659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocapsules embedded in microparticles for enhanced oral bioavailability and efficacy of Lopinavir as an anti-AIDS drug.
    Nassar T; Rohald A; Naraykin N; Barasch D; Amsalem O; Prabhu P; Kotler M; Benita S
    J Drug Target; 2019; 27(5-6):590-600. PubMed ID: 30470150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport.
    Kim KS; Suzuki K; Cho H; Youn YS; Bae YH
    ACS Nano; 2018 Sep; 12(9):8893-8900. PubMed ID: 30088412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS; Raut SY; Reddy MS; Mutalik S
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats.
    Sun M; Zhai X; Xue K; Hu L; Yang X; Li G; Si L
    Eur J Pharm Sci; 2011 Jun; 43(3):132-40. PubMed ID: 21530655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal lymphatic vessels and their role in chylomicron absorption and lipid homeostasis.
    Hokkanen K; Tirronen A; Ylä-Herttuala S
    Curr Opin Lipidol; 2019 Oct; 30(5):370-376. PubMed ID: 31361624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism.
    Wang X; Zhang C; Han N; Luo J; Zhang S; Wang C; Jia Z; Du S
    Drug Deliv; 2021 Dec; 28(1):1664-1672. PubMed ID: 34338567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.
    Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
    J Drug Target; 2014 Dec; 22(10):871-82. PubMed ID: 25148607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system.
    Lee JB; Zgair A; Malec J; Kim TH; Kim MG; Ali J; Qin C; Feng W; Chiang M; Gao X; Voronin G; Garces AE; Lau CL; Chan TH; Hume A; McIntosh TM; Soukarieh F; Al-Hayali M; Cipolla E; Collins HM; Heery DM; Shin BS; Yoo SD; Kagan L; Stocks MJ; Bradshaw TD; Fischer PM; Gershkovich P
    J Control Release; 2018 Sep; 286():10-19. PubMed ID: 30016732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavir.
    Jain S; Sharma JM; Jain AK; Mahajan RR
    Nanomedicine (Lond); 2013 Oct; 8(10):1639-55. PubMed ID: 23351133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal lymphatic transport for drug delivery.
    Yáñez JA; Wang SW; Knemeyer IW; Wirth MA; Alton KB
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):923-42. PubMed ID: 21689702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.